Form 8-K - Current report:
SEC Accession No. 0000950170-24-122816
Filing Date
2024-11-07
Accepted
2024-11-07 08:00:09
Documents
12
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pmvp-20241107.htm   iXBRL 8-K 55666
2 EX-99.1 pmvp-ex99_1.htm EX-99.1 148141
  Complete submission text file 0000950170-24-122816.txt   365451

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pmvp-20241107.xsd EX-101.SCH 49704
14 EXTRACTED XBRL INSTANCE DOCUMENT pmvp-20241107_htm.xml XML 5995
Mailing Address ONE RESEARCH WAY PRINCETON NJ 08540
Business Address ONE RESEARCH WAY PRINCETON NJ 08540 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39539 | Film No.: 241433262
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)